Skip to content

Clinical trials

Diabetes Mellitus, Type 2 trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Country / region: Netherlands Clear all

321 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20016
20025
20036
20049
200511
200617
200712
200817
200921
201022
201117
201216
201312
201417
201514
201613
201713
201810
201910
202011
20219
202212
202311
20249
20257
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed251
Unknown status28
Terminated16
Recruiting14
Active, not recruiting6
Not yet recruiting3
Enrolling by invitation2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Maastricht University Medical Center38
Novo Nordisk A/S38
AstraZeneca22
Sanofi20
Boehringer Ingelheim18
Amsterdam UMC, location VUmc16
Radboud University Medical Center15
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)12
Maastricht University9
Takeda8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2321
Diabetes Mellitus80
Obesity41
Insulin Resistance26
Cardiovascular Diseases13
Diabetes Mellitus, Type 113
Hypertension13
Renal Insufficiency, Chronic13
Dyslipidemias12
Glucose Metabolism Disorders12

Trials

Showing 26 to 50 of 321. Each trial links to its page on Pharma Observatory.

221 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.